CREB1 and epilepsy: MiR-124 can attenuate epileptogenesis by inhibiting apoptosis, neuronal excitability, and prolonging onset latency via inhibiting expression of CREB1 [32], C/EBPα [54], and Bcl2L13 [55], while promoting epilepsy through microglia activation and inflammatory response [54] (Figure 4).